ArticleJournal for immunotherapy of cancer2024

Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy.

Santiago Acero-Bedoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.